Eden Health, the health platform that connects members with independent, licensed providers for personalized health care, announces its acquisition of Contigo Compounding, a licensed 503A compounding pharmacy specializing in sterile and non-sterile custom medications. This acquisition cements Eden’s investment in the future of personalized medicine by integrating compounding capabilities in-house, allowing for precision dosing, innovative delivery formats, and responsive care coordination between providers and pharmacists. Contigo’s state-of-the-art facility, compliant with USP <797> and <800> guidelines, will allow Eden to handle all medication preparation internally.
Read the full article: Eden Health Expands Personalized Care Platform through Acquisition of Contigo Compounding //
Source: https://www.prnewswire.com/news-releases/eden-health-expands-personalized-care-platform-through-acquisition-of-contigo-compounding-302533711.html